Health

A Lot Of EpiPens Are Being Recalled Because Of A Potential Defect

Drugmaker Mylan issued the recall in eight countries, including the U.S.

A Lot Of EpiPens Are Being Recalled Because Of A Potential Defect
Getty Images
SMS

EpiPens have been recalled in eight countries — and that now includes the U.S.

Mylan, the company that manufactures them, issued a recall of over 80,000 EpiPens in Norway, Denmark, Finland, Ireland, Australia, New Zealand, and Japan in late March.

A defect that could prevent some EpiPens from working in an emergency prompted the recall.

These 2 Major Companies Are Taking A Stand Against The $600 EpiPen
These 2 Major Companies Are Taking A Stand Against The $600 EpiPen

These 2 Major Companies Are Taking A Stand Against The $600 EpiPen

Health insurance giant Cigna and CVS Health have made big moves against the pricey brand-name allergy treatment.

LEARN MORE

The company said Friday the issue was extended to the U.S. and certain markets in Europe, Asia and North and South America. The kids version, EpiPen Jr., is also a part of the U.S. recall.

Mylan got a lot of criticism last year when the price for its product increased by over 400 percent. The company's CEO had to testify in front of Congress over the hike.

After that, the Mylan came out with a generic version of the product at nearly half the price. The generic version isn't included in the recent recall.